Cardiac involvement in sarcoidosis

Seminars in Respiratory and Critical Care Medicine

Volumn 23, Issue 6, 2002, Pages 513-527

  Deng, Jane C ^b   Baughman, Robert P ^c   Lynch III, Joseph P ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Arrhythmias; Cardiac; Myocardial; Sarcoidosis; Sudden death

Indexed keywords

ANTIARRHYTHMIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GALLIUM 67; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; TECHNETIUM 99M; THALLIUM 201;

ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; DEFIBRILLATOR; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART MUSCLE BIOPSY; HISTOLOGY; HOLTER MONITORING; HUMAN; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SARCOIDOSIS; SCINTISCANNING; TACHYCARDIA; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0036909396     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36516     Document Type: Article

References (129)

1. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103:253-258
2. Fleming H. Cardiac sarcoidosis. In: James D, ed. Sarcoidosis and Other Granulomatous Disorders. New York: Marcel Dekker; 1994:323-334
3. Shammas RL, Movahed A. Sarcoidosis of the heart. Clin Cardiol 1993;16:462-472
4. Fleming HA. Sarcoid heart disease. Br Heart J 1974;36:54-68
5. Johns CJ, Michele TM. The clinical management of sarcoidosis: A 50-year experience at the Johns Hopkins Hospital. Medicine 1999;78:65-111
6. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-1234
7. Bernstein M, Konzelman FW, Sidlick DM. Boeck's sarcoid: Report of a case with visceral involvement. Arch Intern Med 1929;4:721-734
8. Gentzen G. Uber riesenzellengranulome bei zwei fallen von endocardfibrose. Beitrage zur Pathologischen Anatomie 1937;98:375
9. Scadding JG. Sarcoidosis. London: Eyre and Spottiswoode; 1967:291
10. Gozo EG Jr, Cosnow I, Cohen HC, et al. The heart in sarcoidosis. Chest 1971;60:379-388
11. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63:86-108
12. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-1211
13. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study on fatal myocardial sarcoidosis. Ann NY Acad Sci 1976;278:455-469
14. American Thoracic Society. Statement on sarcoidosis. Am J Respir Crit Care Med 1999;160:736-755
15. Lynch JP III, Sharma OP, Baughman RP. Extrapulmonary sarcoidosis. Semin Respir Infect 1998;13:229-254
16. Kinney EL, Jackson GL, Reeves WC, et al. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction: An analysis of 44 patients. Am J Med 1980;68:497-503
17. Tellier P, Paycha F, Antony I, et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 1988;85:189-193
18. Fahy GJ, Marwick T, McCreery CJ, et al. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 1996;109:62-66
19. Burstow DJ, Tajik AJ, Bailey KR, et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 1989;63:478-482
20. 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest 1977;72:27-32
21. Longscope WT, Freiman DG. A study of sarcoidosis: Based on a combined investigation of 160 cases, including 30 autopsies from Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 1952;3:1-152
22. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119:167-172
23. Iwai K, Skiguchi M, Hosoda Y, et al. Racial differences in cardiac sarcoidosis noted at autopsy. Sarcoidosis 1994;11: 248-251
24. Gideon NM, Mannino DM. Sarcoidosis mortality in the United States 1979-1991: An analysis of multiple-cause mortality data. Am J Med 1996;100:423-427
25. Ghosh P, Fleming HA, Gresham GA, et al. Myocardial sarcoidosis. Br Heart J 1972;34:769-773
26. Sekiguchi M, Numao Y, Imai M, et al. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis, concepts through a study employing endomyocardial biopsy, I: Sarcoidosis. Jpn Circ J 1980;44:249-263
27. Sekiguchi M, Yazaki Y, Isobe M, et al. Cardiac sarcoidosis: Diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996;10:495-510
28. Tachibana T, Ohmori F, Ueda E. Clinical study on cardiac sarcoidosis. Ann NY Acad Sci 1986;465:530-542
29. Virmani R, Bures JC, Roberts WC. Cardiac sarcoidosis: A major cause of sudden death in young individuals. Chest 1980;77:423-428
30. Fleming HA. Sarcoid heart disease. Br Med J 1973;1:174-175
31. Stewart RE, Graham DM, Godfrey GW, et al. Rapidly progressive heart failure resulting from cardiac sarcoidosis. Am Heart J 1988;115:1324-1326
32. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001;88:1006-1010
33. Israel RH, Poe RH. Massive pericardial effusion in sarcoidosis. Respiration 1994;61:176-180
34. Garrett J, O'Neill H, Blake S. Constrictive pericarditis associated with sarcoidosis. Am Heart J 1984;107:394
35. Yazaki Y, Hongo M, Hiroyoshi Y, et al. Cardiac sarcoidosis in Japan: Treatment and prognosis. In: Sekiguchi M, Richardson PJ, eds. Prognosis and Treatment of Cardiomyopathy and Myocarditis. Tokyo: Univ of Tokyo Press; 1994:351-353
36. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998;82:537-540
37. Lull RJ, Dunn BE, Gregoratos G, et al. Ventricular aneurysm due to cardiac sarcoidosis with surgical cure of refractory ventricular tachycardia. Am J Cardiol 1972;30:282-287
38. Zoneraich S, Gupta MP, Mehta J, et al. Myocardial sarcoidosis presenting as acute mitral insufficiency. Chest 1974;66:452-454
39. Raftery EB, Oakley CM, Goodwin JF. Acute subvalvar mitral incompetence. Lancet 1966;2:360-365
40. Sharma OP. Cardiac and neurologic dysfunction in sarcoidosis. Clin Chest Med 1997;18:813-825
41. Kinney E, Murthy R, Ascunce G, et al. Pericardial effusions in sarcoidosis. Chest 1979;76:476-478
42. Angomachalelis N, Hourzamanis A, Salem N, et al. Pericardial effusion concomitant with specific heart muscle disease in systemic sarcoidosis. Postgrad Med J 1994;70(suppl):S8-S12
43. Shiff AD, Blatt CJ, Colp C. Recurrent pericardial effusion secondary to sarcoidosis of the pericardium. N Engl J Med 1969;281:141-143.
44. Lewin RF, Mor R, Spitzer S, et al. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985;110:116-122
45. Gregor P, Widimsky P, Sladkova T, et al. Echocardiography in sarcoidosis. Jpn Heart J 1984;25:499-508
46. Verkleeren JL, Glover MU, Bloor C, et al. Cardiac tamponade secondary to sarcoidosis. Am Heart J 1983;106:601-603
47. Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995;107:330-334
48. Numao Y, Sekiguchi M, Fruie T, et al. A study of cardiac involvement in 963 cases of sarcoidosis by ECG and endomyocardial biopsy. Ann NY Acad Sci 1976;76:607-614
49. Thunell M, Bjerle P, Stjernberg N. ECG abnormalities in patients with sarcoidosis. Acta Med Scand 1983;213:115-118
50. Stein E, Jackler I, Stimmel G, et al. Asymptomatic electrocardiographic alterations in sarcoidosis. Am Heart J 1973;86:474-477
51. Gibbons WJ, Levy RD, Nava S, et al. Subclinical cardiac dysfunction in sarcoidosis. Chest 1991;100:44-50
52. Suzuki T, Kanda T, Kubota S, et al. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994;106:1021-1024
53. Thunell M, Bjerle P, Karp K, et al. Exercise test in patients with sarcoidosis: The importance of repolarization disturbances. Acta Med Scand 1988;223:69-73
54. Friart A, Philippart C, Bruart J. Echocardiography in systemic sarcoidosis. Lancet 1987;1:513
55. Moiseyev SV, Kornev BM, Shatkovsky NP, et al. Noninvasive diagnosis of cardiac sarcoidosis. Lancet 1987;2:739-740
56. Winters SL, Cohen M, Grennberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy, and an implantable antitachycardia device. J Am Coll Cardiol 1997;18:937-943
57. Le Guludec D, Menad F, Faraggi M, et al. Myocardial sarcoidosis: Clinical value of technetium-99m sestamibi tomoscintigraphy. Chest 1994;106:1675-1682
58. Tellier P, Valeyre D, Nitenberg A, et al. Cardiac sarcoidosis: Reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med 1985;11:201-204
59. Yamamoto N, Gotoh K, Yagi Y, et al. Thallium-201 myocardial SPECT findings at rest in sarcoidosis. Ann Nucl Med 1993;7:97-103
60. Valeyre D, Marsac J, Gambini G, et al. Assessment of sarcoid heart disease: A study of 37 patients with thoracic sarcoidosis. In: Chretien J, Marsag J, Saltiel JC, eds. Sarcoidosis and Other Granulomatous Diseases. Oxford: Pergamon; 1983:296-300
61. Haywood LJ, Sharma OP, Siegel ME, et al. Detection of myocardial sarcoidosis by thallium 201 imaging. J Natl Med Assoc 1982;74:959-964
62. Fields CL, Ossorio MA, Roy TM, et al. Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis. South Med J 1990;83:339-342
63. 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med 1997;18:799-811
64. Nitenberg A, Foult JM, Blanchet F, et al. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol 1985;55:748-754
65. Kahan A, Nitenberg A, Foult JM, et al. Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 1985;28:637-646
66. Wait JL, Movahed A. Anginal chest pain in sarcoidosis. Thorax 1989;44:391-395
67. Kinney EL, Caldwell JW. Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology 1990;41:573-576
68. Tajima T, Naito T, Dohi Y, et al. Ga-67 and T1-201 imaging in sarcoidosis involving the myocardium. Clin Nucl Med 1981;6:120-121
69. Nagatomo Y, Imamura T, Koiwaya Y, et al. Thallium-201 and gallium-67 myocardial scintigraphy for the evaluation of sarcoid involvement. Clin Nucl Med 1987;12:335-336
70. Hirose Y, Ishida Y, Hayashida K, et al. Myocardial involvement in patients with sarcoidosis: An analysis of 75 patients. Clin Nucl Med 1994;19:522-526
71. Kurata C, Sakata K, Taguchi T, et al. SPECT imaging with TI-201 and Ga-67 in myocardial sarcoidosis. Clin Nucl Med 1990;15:408-411
72. Taki J, Nakajima K, Bunko H, et al. Cardiac sarcoidosis demonstrated by T1-201 and Ga-67 SPECT imaging. Clin Nucl Med 1990;15:636-639
73. Tawarahara K, Kurata C, Okayama K, et al. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J 1992;124:1383-1384
74. Riedy K, Fisher MR, Belic N, et al. MR imaging of myocardial sarcoidosis. Am J Roentgenol 1988;151:915-916
75. O'Connell JB, Henkin RE, Robinson JA, et al. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation 1984;70:58-62
76. Forman MB, Sandler MP, Sacks GA, et al. Radionuclide imaging in myocardial sarcoidosis: demonstration of myocardial uptake of technetium 99m pyrophosphate and gallium. Chest 1983;83:578-580
77. Angomachalelis N. Radionuclide imaging of specific heart muscle disease in systemic sarcoidosis. Sarcoidosis 1992;9:245-253
78. Eguchi M, Tsuchihashi K, Hotta D, et al. Technetium-99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology 2000;94:193-199
79. DePuey EG, Jones ME, Garcia EV. Evaluation of right ventricular regional perfusion with technetium-99m-sestamibi SPECT. J Nucl Med 1991;32:1199-1205
80. Nishijima K, Miyahara Y, Furukawa K, et al. Simultaneous assessment of right ventricular function and hypertrophy by Tc-99m MIBI. Clin Nucl Med 1999;24:151-155
81. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110:520-527
82. Doherty MJ, Kumar SK, Nicholson AA, et al. Cardiac sarcoidosis: The value of magnetic resonance imaging in diagnosis and assessment of response to treatment. Respir Med 1998;92:697-699
83. Eliasch H, Juhlin-Dannfelt A, Sjogren I, et al. Magnetic resonance imaging as an aid to the diagnosis and treatment evaluation of suspected myocardial sarcoidosis in a fighter pilot. Aviat Space Environ Med 1995;66:1010-1013
84. Matsuki M, Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol 2000;55:323-325
85. Dupis JM, Victor J, Furber A, et al. Magnetic resonance imaging in cardiac sarcoidosis: A case report. Arch Mal Coeur 1994;87:105-110
86. Chandra M, Silverman ME, Oshinski J, et al. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 1996;110:562-565
87. Bajaj AK, Kopelman HA, Echt DS. Cardiac sarcoidosis with sudden death: Treatment with the automatic implantable cardioverter defibrillator. Am Heart J 1988;116:557-560
88. Danias PG. Gadolinium-enhanced cardiac magnetic resonance imaging: Expanding the spectrum of clinical applications. Am J Med 2001;110:591-592
89. Takeda N, Yokoyama I, Hiroi Y, et al. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 2002;105:1144-1145
90. Okumura W, Iwasaki T, Ueda T, et al. [Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis]. Kaku Igaku 1999;36:341-348
91. Ishikawa T, Kondoh H, Nakagawa S, et al. Steroid therapy in cardiac sarcoidosis: Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest 1984;85:445-447
92. Lorell B, Alderman EL, Mason JW. Cardiac sarcoidosis: Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 1978;42:143-146
93. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302
94. Ramer SJ, Fenoglio JJ, Ursell P. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986;90:528-533
95. Shammas RL, Movahed A. Successful treatment of myocardial sarcoidosis with steroids. Sarcoidosis 1994;11:37-39
96. Valantine HA, Tazelaar HD, Macoviak J, et al. Cardiac sarcoidosis: Response to steroids and transplantation. J Heart Transplant 1987;6:244-250
97. Lopez JA, Hogan PJ, Fish RD, et al. Cardiac sarcoidosis: An unusual form of acute congestive cardiomyopathy. Tex Heart Inst J 1995;22:265-267
98. Takada K, Ina Y, Yamamoto M, et al. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan: Clinical evaluation of corticosteroid therapy. Sarcoidosis 1994;11: 113-117
99. Baughman RP, Sharma OP, Lynch JP III. Sarcoidosis: Is therapy effective? Semin Respir Infect 1998;13:255-273
100. Baughman RP, Ohmichi M, Lower EE. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:133-137
101. Lynch JP III, McCune WJ. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 1997;155:395-420
102. Zic JA, Horowitz DH, Arzubiaga C, et al. Treatment of cutaneous sarcoidosis with chloroquine: Review of the literature. Arch Dermatol 1991;127:1034-1040
103. Baltzan M, Mehta S, Kirkham TH, et al. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999;160:192-197
104. Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 1989;111:437-438
105. Sharma OP. Neurosarcoidosis: A personal perspective based on the study of 37 patients. Chest 1997;112:220-228
106. Kaye O, Palazzo E, Grossin M, et al. Low-dose methotrexate: An effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 1995;34:642-644
107. Webster GF, Razsi LK, Sanchez M, et al. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991;24:451-454
108. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999;54:742-746
109. Muller-Quernheim J, Kienast K, Held M, et al. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 1999;14:1117-1122
110. Agbogu BN, Stern BJ, Sewell C, et al. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995;52:875-879
111. Lower EE, Broderick JP, Brott TG, et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997;157:1864-1868
112. Demeter SL. Myocardial sarcoidosis unresponsive to steroids: Treatment with cyclophosphamide. Chest 1988;94:202-203
113. Stern BJ, Schonfeld SA, Sewell C, et al. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992;49:1065-1072
114. Martinet Y, Pinkston P, Saltini C, et al. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am Rev Respir Dis 1988;138:1242-1248
115. Wyser CP, van Schalkwyk EM, Alheit B, et al. Treatment of progressive pulmonary sarcoidosis with cyclosporin A: A randomized controlled trial. Am J Respir Crit Care Med 1997;156:1371-1376
116. Carlesimo M, Giustini S, Rossi A, et al. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995;32:866-869
117. Baughman RP, Judson MA, Teirstein AS, et al. Thalidomide for chronic sarcoidosis. Chest 2002;122:227-232
118. Zabel P, Entzian P, Dalhoff K, et al. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 1997;155: 1665-1669
119. Baughman RP. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:70-74
120. Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001;135:27-31
121. Mezaki T, Chinushi M, Washizuka T, et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis: Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med 40:731-735
122. Huang PL, Brooks R, Carpenter C, et al. Antiarrhythmic therapy guided by programmed electrical stimulation in cardiac sarcoidosis with ventricular tachycardia. Am Heart J 1991;121:599-601
123. Kowey PR, Waxman HL, Greenspon A, et al. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group. Am J Cardiol 1990;65: 594-598
124. Poll DS, Marchlinski FE, Buxton AE, et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:992-997
125. Paz HL, McCormick DJ, Kutalek SP, et al. The automated implantable cardiac defibrillator: Prophylaxis in cardiac sarcoidosis. Chest 1994;106:1603-1607
126. Harris IM, Guarino R. Cardiac sarcoidosis: A new approach to treatment. Cardiovasc Surg 1994;2:420-422
127. Jain A, Starek PJ, Delany DL. Ventricular tachycardia and ventricular aneurysm due to unrecognized sarcoidosis. Clin Cardiol 1990;13:738-740
128. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: Control with augmented corticosteroids. J Heart Lung Transplant 1992;11:367-369
129. Martinez FJ, Orens JB, Deeb M, et al. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest 1994;106:1597-1599